Robert Francomano
2019
In 2019, Robert Francomano earned a total compensation of $2.1M as Chief Commercial Officer at Stemline Therapeutics.
Compensation breakdown
| Bonus | $222,600 |
|---|---|
| Salary | $410,000 |
| Stock Awards | $1,435,327 |
| Total | $2,067,927 |
Francomano received $1.4M in stock awards, accounting for 69% of the total pay in 2019.
Francomano also received $222.6K in bonus and $410K in salary.
Rankings
In 2019, Robert Francomano's compensation ranked 5,760th out of 13,971 executives tracked by ExecPay. In other words, Francomano earned more than 58.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,760 out of 13,971 | 59th |
Division Manufacturing | 2,156 out of 5,701 | 62nd |
Major group Chemicals And Allied Products | 776 out of 2,200 | 65th |
Industry group Drugs | 653 out of 1,886 | 65th |
Industry Pharmaceutical Preparations | 480 out of 1,398 | 66th |
Source: SEC filing on April 29, 2020.
Francomano's colleagues
We found three more compensation records of executives who worked with Robert Francomano at Stemline Therapeutics in 2019.